BioCentury
ARTICLE | Financial News

Lorus completes follow-on

December 9, 2013 8:00 AM UTC

Lorus Therapeutics Inc. (TSX: LOR; Pink:LRUSF), Toronto, Ontario Business: Cancer, Gene/Cell therapy Date completed: 11/22/13 Type: Follow-on Raised: C$7 million ($6.6 million) Shares: 12.7 million Pr...